Cooley advised Olema Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised TD Cowen, as sales agent. Olema Pharmaceuticals ((“Olema”, Nasdaq: OLMA) announced its $150...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Venable advised Tapestry, Inc. on the offering, and Davis Polk & Wardwell advised the underwriters. Tapestry, Inc. (NYSE: TPR) (the “Company”) has...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Venable advised Tapestry, Inc. on the offering, and Davis Polk & Wardwell advised the underwriters. Tapestry, Inc. (NYSE: TPR) (the “Company”) has...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Morgan Stanley & Co. LLC and Wedbush Securities Inc. on the offering. TScan Therapeutics, a biopharmaceutical company, has announced a $140.6 million SEC-registered common...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Beyond Meat, and Davis Polk advised the sales agent for the offering. Beyond Meat, Inc. announced an SEC-registered at-the-market offering of shares...
You must be a Standard 1 Year member to access this content.
NautaDutilh and Kirkland & Ellis advised InflaRx on the offering, and Davis Polk advised the representative of the underwriters involved. InflaRx N.V. announced a public offering...
You must be a Standard 1 Year member to access this content.
Skadden advised Trimble, and Davis Polk advised the representatives of the several underwriters. Trimble Inc. announced an SEC-registered offering of $800 million aggregate principal amount of...
You must be a Standard 1 Year member to access this content.
